| Nov 8, 2024 |
Nov 12, 2024 |
Aurinia Pharmaceuticals Inc.
|
Director |
Sell |
46.3
|
-5,241
|
-29.26%
|
✗
|
$44.2K |
| May 7, 2021 |
May 11, 2021 |
Emergent BioSolutions Inc.
|
EVP, Chief Medical Officer |
Sell |
26.3
|
-305
|
-2.50%
|
✗
|
$18.6K |
| Mar 5, 2018 |
Mar 7, 2018 |
Jazz Pharmaceuticals plc
|
EVP, R&D and CMO |
Sell |
22.5
|
-648
|
-2.23%
|
✗
|
$92.9K |
| Feb 26, 2018 |
Feb 28, 2018 |
Jazz Pharmaceuticals plc
|
EVP, R&D and CMO |
Sell |
22.5
|
-525
|
-2.43%
|
✗
|
$77.4K |
| May 11, 2017 |
May 12, 2017 |
Jazz Pharmaceuticals plc
|
EVP, R&D and CMO |
Sell |
82.5
|
+359
|
1.70%
|
✗
|
$99.5K |
| Feb 27, 2017 |
Mar 1, 2017 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Sell |
22.5
|
-571
|
-4.01%
|
✗
|
$78.2K |
| Aug 12, 2016 |
Aug 12, 2016 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Buy |
87.5
|
+608
|
4.48%
|
✓
|
$83.4K |
| Jul 13, 2016 |
Jul 13, 2016 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Buy |
87.5
|
+580
|
4.46%
|
✓
|
$83.3K |
| Jun 13, 2016 |
Jun 15, 2016 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Buy |
87.5
|
+557
|
4.48%
|
✓
|
$83.3K |
| May 11, 2016 |
May 12, 2016 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Sell |
22.5
|
-641
|
-4.92%
|
✗
|
$95.4K |
| Apr 13, 2016 |
Apr 15, 2016 |
Jazz Pharmaceuticals plc
|
Global Head of R&D and CMO |
Sell |
36.3
|
-103
|
-0.78%
|
✗
|
$15.2K |